With the analysis among 1,207 patents, we discovered top 269 key players by total patent application. Senju Pharmaceutical Beijing Co. Ltd., Allergan, Inc., Rohto Pharmaceutical Co., Ltd. are dominant in this area. They take 8.78% of the total patent filing.
Senju Pharmaceutical Beijing Co. Ltd.
Beijing Shi, China
Patent: 42
California, United States
Patent: 37
Rohto Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 27
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 22
Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH
Berlin, Germany
Patent: 22
Foresight Biotherapeutics, Inc.
New York, United States
Patent: 20
Massachusetts, United States
Patent: 19
Basel-Stadt, Switzerland
Patent: 18
Santen Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 18
With the analysis among 47 patents, we discovered top 9 start-ups by total patent application. TearClear Corp., Visus Therapeutics, Inc., Just - Evotec Biologics, Inc. are active in this area.
Massachusetts, United States
Patent: 14
Washington, United States
Patent: 9
Just - Evotec Biologics, Inc.
Washington, United States
Patent: 7
North Carolina, United States
Patent: 6
California, United States
Patent: 3
Trefoil Therapeutics, Inc.
California, United States
Patent: 3
Kedalion Therapeutics, Inc.
California, United States
Patent: 3
Pennsylvania, United States
Patent: 1
Pennsylvania, United States
Patent: 1
With the analysis among related 352 patents applied in the last 5 years. We discover 125 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., TearClear Corp., Ocular Sciences SAS take 12.78% of patent filing during this period.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 17
Massachusetts, United States
Patent: 14
Chengdu Ruimu Biomedical Technology Co., Ltd.
Sichuan Sheng, China
Patent: 9
Shenyang Sinqi Ophthalmic Medications Holdings Co., Ltd.
Liaoning Sheng, China
Patent: 8
Chemisches Institut Schaefer AG
Basel-Landschaft, Switzerland
Patent: 8
California, United States
Patent: 7
Washington, United States
Patent: 6
North Carolina, United States
Patent: 6
With the analysis among related 352 patents in last 5 years, we discover 85 new entrants. TearClear Corp., Ocular Sciences SAS, Chengdu Ruimu Biomedical Technology Co., Ltd. are the most active new entrants in this area.
Massachusetts, United States
Patent: 14
Chengdu Ruimu Biomedical Technology Co., Ltd.
Sichuan Sheng, China
Patent: 9
Chemisches Institut Schaefer AG
Basel-Landschaft, Switzerland
Patent: 8
California, United States
Patent: 7
North Carolina, United States
Patent: 6
Minnesota, United States
Patent: 5
Nordrhein-Westfalen, Germany
Patent: 5
Aldeyra Therapeutics, Inc.
Massachusetts, United States
Patent: 4
With the analysis among 114 patents, we discovered top 32 universities and scientific research institutions by total patent application. University of Western Sydney, Nanyang Technological University, Shenyang Pharmaceutical University are dominant in this area. They take 21.93% of the total patent filing.
University of Western Sydney
New South Wales, Australia
Patent: 11
Nanyang Technological University
Central Region, Singapore
Patent: 5
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 4
Tianjin University of Traditional Chinese Medicine
Tianjin Shi, China
Patent: 3
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 3
The Johns Hopkins University
São Paulo, Brazil
Patent: 2
Jilin Sheng, China
Patent: 2
The Hong Kong Polytechnic University
Hong Kong SAR, China
Patent: 2
Sichuan Sheng, China
Patent: 2